CING
Price
$3.33
Change
-$0.47 (-12.37%)
Updated
Nov 13 closing price
Capitalization
18.67M
Intraday BUY SELL Signals
VRAX
Price
$0.48
Change
+$0.02 (+4.35%)
Updated
Nov 13 closing price
Capitalization
2.11M
Intraday BUY SELL Signals
Interact to see
Advertisement

CING vs VRAX

Header iconCING vs VRAX Comparison
Open Charts CING vs VRAXBanner chart's image
Cingulate
Price$3.33
Change-$0.47 (-12.37%)
Volume$381.91K
Capitalization18.67M
Virax Biolabs Group
Price$0.48
Change+$0.02 (+4.35%)
Volume$54.46K
Capitalization2.11M
CING vs VRAX Comparison Chart in %
CING
Daily Signal:
Gain/Loss:
VRAX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CING vs. VRAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CING is a Hold and VRAX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (CING: $3.33 vs. VRAX: $0.48)
Brand notoriety: CING and VRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CING: 193% vs. VRAX: 20%
Market capitalization -- CING: $18.67M vs. VRAX: $2.11M
CING [@Biotechnology] is valued at $18.67M. VRAX’s [@Biotechnology] market capitalization is $2.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CING’s FA Score shows that 1 FA rating(s) are green whileVRAX’s FA Score has 0 green FA rating(s).

  • CING’s FA Score: 1 green, 4 red.
  • VRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, CING is a better buy in the long-term than VRAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CING’s TA Score shows that 3 TA indicator(s) are bullish while VRAX’s TA Score has 3 bullish TA indicator(s).

  • CING’s TA Score: 3 bullish, 6 bearish.
  • VRAX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, VRAX is a better buy in the short-term than CING.

Price Growth

CING (@Biotechnology) experienced а -9.51% price change this week, while VRAX (@Biotechnology) price change was -3.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CING($18.7M) has a higher market cap than VRAX($2.11M). CING YTD gains are higher at: -32.454 vs. VRAX (-79.502). VRAX has higher annual earnings (EBITDA): -6.43M vs. CING (-17.21M). CING has more cash in the bank: 8.9M vs. VRAX (7.29M). VRAX has less debt than CING: VRAX (380K) vs CING (6.58M). VRAX has higher revenues than CING: VRAX (84.9K) vs CING (0).
CINGVRAXCING / VRAX
Capitalization18.7M2.11M888%
EBITDA-17.21M-6.43M268%
Gain YTD-32.454-79.50241%
P/E Ratio0.02N/A-
Revenue084.9K-
Total Cash8.9M7.29M122%
Total Debt6.58M380K1,732%
TECHNICAL ANALYSIS
Technical Analysis
CINGVRAX
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 3 days ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CING
Daily Signal:
Gain/Loss:
VRAX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HE11.560.07
+0.61%
Hawaiian Electric Industries
DSGN7.61-0.15
-1.93%
Design Therapeutics
TIMB23.28-0.49
-2.06%
TIM SA
MDIA0.90-0.03
-3.23%
Mediaco Holding
CHR0.05N/A
-4.55%
Cheer Holding

CING and

Correlation & Price change

A.I.dvisor indicates that over the last year, CING has been loosely correlated with ABCL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CING jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CING
1D Price
Change %
CING100%
-12.37%
ABCL - CING
34%
Loosely correlated
-8.82%
RXRX - CING
30%
Poorly correlated
-6.88%
BEIGF - CING
29%
Poorly correlated
N/A
GOVX - CING
29%
Poorly correlated
-5.80%
ELVN - CING
29%
Poorly correlated
-0.15%
More

VRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRAX has been loosely correlated with ALZN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VRAX jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRAX
1D Price
Change %
VRAX100%
-1.15%
ALZN - VRAX
45%
Loosely correlated
-0.85%
CUE - VRAX
35%
Loosely correlated
-2.25%
NTRB - VRAX
31%
Poorly correlated
-3.78%
PTGX - VRAX
30%
Poorly correlated
-0.83%
CING - VRAX
30%
Poorly correlated
+3.54%
More